These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 8413413)

  • 1. Clinical implications of the p53 tumor-suppressor gene.
    Harris CC; Hollstein M
    N Engl J Med; 1993 Oct; 329(18):1318-27. PubMed ID: 8413413
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of the p53 tumor-suppressor gene.
    Rutz HP; Mirimanoff RO
    N Engl J Med; 1994 Mar; 330(12):864-5. PubMed ID: 8114848
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of the p53 tumor-suppressor gene.
    Müller M; Volkmann M; Zentgraf H; Galle PR
    N Engl J Med; 1994 Mar; 330(12):865. PubMed ID: 8166834
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of the p53 tumor-suppressor gene.
    Bokemeyer C; Kuczyk MA; Sehrt J
    N Engl J Med; 1994 Mar; 330(12):865. PubMed ID: 8114849
    [No Abstract]   [Full Text] [Related]  

  • 5. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model.
    Greenblatt MS; Grollman AP; Harris CC
    Cancer Res; 1996 May; 56(9):2130-6. PubMed ID: 8616861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Environmental carcinogens and p53 gene mutation].
    Xu Z; Jin Y
    Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].
    Tsuchida N; Gao C; Tsuchida Y; Nakajima T; Nishigaki R
    Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1742-51. PubMed ID: 10897687
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer genes. Telling changes of base.
    Harris AL
    Nature; 1991 Apr; 350(6317):377-8. PubMed ID: 2011186
    [No Abstract]   [Full Text] [Related]  

  • 13. p53--master and commander.
    Foulkes WD
    N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
    [No Abstract]   [Full Text] [Related]  

  • 14. [P53 and cancers].
    May P; May E
    Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The tumor suppressor gene p53 (part 2). Applications in human pathology].
    Martin A
    Ann Pathol; 1995; 15(3):184-91. PubMed ID: 7639854
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary.
    Sarvary E; Nagy P; Benjamin A; Szoke M; Remport A; Jansen J; Nemes B; Kobori L; Fehervari I; Sulyok B; Perner F; Varga M; Fazakas J; Lakatos M; Szabo M; Toth A; Járay J
    Transplant Proc; 2005 Mar; 37(2):969-72. PubMed ID: 15848594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival.
    Hainaut P
    Curr Opin Oncol; 1995 Jan; 7(1):76-82. PubMed ID: 7696367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy.
    Soussi T
    Immunol Today; 1996 Aug; 17(8):354-6. PubMed ID: 8783493
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of p53 mutations in human cancers.
    Pellegata NS; Ranzani GN
    Eur J Histochem; 1996; 40(4):273-82. PubMed ID: 9116334
    [No Abstract]   [Full Text] [Related]  

  • 20. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.